Published in
Impact Journals, Oncotarget, 51(7), p. 85124-85141, 2016
DOI: 10.18632/oncotarget.13200
Links
Tools
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
Journal article published in 2016 by
Sophie Vacher,
Véronique Becette,
Franck Assayag,
Camille Benoist,
Sandrine Tury 
,
Maud Kamal,
Elisabetta Marangoni,
Ivan Bièche,
Florence Lerebours,
Céline Callens
,
Maud Kamal,
Elisabetta Marangoni,
Ivan Bièche,
Florence Lerebours,
Céline Callens
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 